Internal Medicine | Page 240 of 487 | Links Medicus Content Curation & Alerts in Medicine

CDC Guidelines for Gonococcal Infection, 2020. CDC recommends a single 500 mg intramuscular dose of ceftriaxone for uncomplicated gonorrhea, with oral doxycycline for 7 days when chlamydial coinfection has not been excluded

18 Dec, 2020 | 09:40h | UTC

Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020 – Centers for Disease Control and Prevention

Commentary: CDC Guidelines Recommend Ceftriaxone Monotherapy for Uncomplicated Gonorrhea – NEJM Journal Watch

Commentary on Twitter

https://twitter.com/GarrettHile/status/1339732944613720064

Meta-analysis: Lung cancer screening using low-dose computed tomography reduces lung cancer–specific mortality, albeit with a tradeoff of likely overdiagnosis

16 Dec, 2020 | 10:08h | UTC

Cancer-Specific Mortality, All-Cause Mortality, and Overdiagnosis in Lung Cancer Screening Trials: A Meta-Analysis – Annals of Family Medicine

ACG Clinical Guideline: Management of irritable bowel syndrome

16 Dec, 2020 | 10:09h | UTC

ACG Clinical Guideline: Management of Irritable Bowel Syndrome – The American Journal of Gastroenterology

Randomized trial: Dexamethasone for chronic subdural hematoma resulted in fewer favorable outcomes and more adverse events than placebo at 6 months

17 Dec, 2020 | 09:02h | UTC

Trial of Dexamethasone for Chronic Subdural Hematoma – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Dexamethasone should be avoided in patients with chronic subdural haematoma – University of Cambridge AND Dexamethasone for Chronic Subdural Hematoma? – NEJM Journal Watch

Commentary on Twitter

In a trial that compared a 2-week course of dexamethasone with placebo in patients with a chronic subdural hematoma, a favorable outcome on the modified Rankin scale at 6 months was more common in the placebo group than in the dexamethasone group.

— NEJM (@NEJM) December 17, 2020

Guideline: ADA 2021 Standards of Medical Care in Diabetes

10 Dec, 2020 | 00:11h | UTC

Just published! New ADA 2022 Guideline for the Management of Diabetes

Guideline Homepage: ADA 2021 Standards of Medical Care in Diabetes – American Diabetes Association (free supplement)

See ADA 2021 Guideline topics below:

Introduction: Standards of Medical Care in Diabetes—2021

Summary of Revisions: Standards of Medical Care in Diabetes—2021

Commentary on Twitter

ADA's "Standards of Medical Care in Diabetes—2021" is finally here! Featuring American Diabetes Association's latest clinical practice recommendations, the global standard for diabetes care. #ADASOC2021

📖 READ NOW (OPEN ACCESS): https://t.co/VyIT2yJnW8 pic.twitter.com/vOM5XXKLoU

— ADA Professional Publications (@ADA_Pubs) December 9, 2020

Survey study: Sleep-related impairment among doctors linked to increased clinically significant medical errors

17 Dec, 2020 | 08:53h | UTC

Assessment of Physician Sleep and Wellness, Burnout, and Clinically Significant Medical Errors – JAMA Network Open

Commentaries: Lack of sleep tied to physician burnout, medical errors – MedicalXpress AND Poor Physician Sleep Associated with More Medical Errors – NEJM Journal Watch

Commentary on Twitter

Survey study: sleep-related impairment associated with higher burnout & lower professional fulfillment, as well as independent dose-response association with self-reported physician medical errors. @StanfordMed https://t.co/FPk4tYnDT1

— JAMA Network Open (@JAMANetworkOpen) December 9, 2020

Randomized trial: In surgical patients at moderate or high risk of venous thromboembolism, pharmaco-thromboprophylaxis alone is as good as the combination of pharmaco-thromboprophylaxis and graduated compression stockings

16 Dec, 2020 | 10:00h | UTC

Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis: the GAPS non-inferiority RC – Health Technology Assessment

COVID-19 is 10 times deadlier for people with Down syndrome, raising calls for early vaccination

17 Dec, 2020 | 08:51h | UTC

COVID-19 is 10 times deadlier for people with Down syndrome, raising calls for early vaccination – Science

Study: Filtration efficiency of face masks used by the public during the COVID-19 pandemic are, in many cases, nearly equivalent to or better than their non-N95 respirator medical mask counterparts

17 Dec, 2020 | 08:43h | UTC

Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19 Pandemic – JAMA Internal Medicine

Editorial: Filtration Efficiency of Face Masks Used by the Public During the COVID-19 Pandemic

Commentary: Researchers Rank Various Mask Protection, Modifications Against COVID-19 – University of North Carolina School of Medicine

Commentary on Twitter

Marked reassurance on the value of cloth masks.
A new @JAMAInternalMed assessment today https://t.co/bTrurKeG71 Attention to fit is key, such as aluminum nose bridge, ties, no beard, etc 😷😷 @Phillip_Clapp @UNC_SOM pic.twitter.com/ZCMTT2OWXc

— Eric Topol (@EricTopol) December 11, 2020

Individual and community-level risk predictor for COVID-19 mortality in the US, with risk calculator

16 Dec, 2020 | 09:42h | UTC

Individual and community-level risk for COVID-19 mortality in the United States – Nature Medicine

Calculator: Covid-19 risk

Commentary on Twitter

New @NatureMedicine
What is your individualized risk of dying from covid19?https://t.co/Bg61t3raVN https://t.co/tQGH0ilsmR (1.1X for me) pic.twitter.com/9pkwyCUAVw

— Eric Topol (@EricTopol) December 11, 2020

COVID-19 mimics on chest CT: a pictorial review and radiologic guide

17 Dec, 2020 | 08:37h | UTC

COVID-19 mimics on chest CT: a pictorial review and radiologic guide – British Institute of Radiology

Video (5min): Ivermectin for COVID-19 | A Doctor Explains

16 Dec, 2020 | 09:43h | UTC

Ivermectin For COVID-19 | A Doctor Explains – ZDoggMD

Longer time spent at home during COVID-19 pandemic is associated with binge drinking among US adults

16 Dec, 2020 | 09:36h | UTC

Longer time spent at home during COVID-19 pandemic is associated with binge drinking among US adults – The American Journal of Drug and Alcohol Abuse

Commentaries: New study shows every week of lockdown increases binge drinking – MedicalXpress AND Study finds more binge drinking during stay-at-home lockdowns – MedicalXpress

Report: Lung transplantation for 3 patients with severe COVID-19

16 Dec, 2020 | 09:34h | UTC

Lung transplantation for patients with severe COVID-19 – Science Translational Medicine

Commentaries: COVID-19 can damage lungs so badly that ‘only hope’ is transplant – MedicalXpress

Commentary on Twitter

Case reports from 3 patients with severe #COVID19 who received lung transplants show the disease can cause extensive lung damage similar to that seen in pulmonary #fibrosis, and hints transplantation may be a viable treatment. @NUFeinbergMed @ScienceTM https://t.co/wXi0tx8gFg pic.twitter.com/vyerJLlJxi

— Science Magazine (@ScienceMagazine) November 30, 2020

Consensus Guideline: Defining and managing COVID-19-associated pulmonary aspergillosis

15 Dec, 2020 | 01:42h | UTC

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance – The Lancet Infectious Diseases

The coronavirus at 1: A year into the pandemic, what scientists know about how it spreads, infects, and sickens

15 Dec, 2020 | 01:42h | UTC

The coronavirus at 1: A year into the pandemic, what scientists know about how it spreads, infects, and sickens – STAT

[Preprint] RECOVERY trial: Azithromycin does not improve outcomes in hospitalized patients with COVID-19

15 Dec, 2020 | 01:44h | UTC

Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv

News release: RECOVERY trial finds no benefit from azithromycin in patients hospitalised with COVID-19

Commentary: Expert reaction to preprint from the RECOVERY trial on the antibiotic azithromycin in patients hospitalised with COVID-19, reporting no benefit – Science Media Centre

Commentary on Twitter

New RECOVERY result. In patients hospitalised with COVID-19, azithromycin did not provide any clinical benefit. 28 day mortality (19% vs 19%) (rate ratio 1·00; 95% confidence interval [CI] 0·90-1·12; p=0·99). No effect on secondary outcomes either.https://t.co/PTklz40WKr pic.twitter.com/NCzvRIND0S

— Peter Horby @peterhorby.bsky.social (@PeterHorby) December 14, 2020

AHA Scientific Statement: Menopause transition and cardiovascular disease risk

15 Dec, 2020 | 01:32h | UTC

Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association – Circulation

News release: Heart disease risk in women increases leading up to menopause; early intervention is key – American Heart Association

Top Things to Know: Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention

Commentaries: Menopause Transition and Cardiovascular Health: Time Matters – American Heart Association AND Report on latest menopause science looks at heart risks – American Heart Association AND Menopause Transition and CVD Risk: AHA Scientific Statement – American College of Cardiology

Randomized trial: Among women with urinary incontinence, biofeedback-mediated intensive pelvic floor training does not provide additional benefit to basic pelvic floor muscle training

15 Dec, 2020 | 01:23h | UTC

Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: the OPAL RCT – Health Technology Assessment

Randomized trial: Baricitinib plus remdesivir reduce recovery time in patients with COVID-19

13 Dec, 2020 | 23:31h | UTC

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 – New England Journal of Medicine

Commentary: Baricitinib plus remdesivir shows promise for treating COVID-19 – NIH News Releases

Commentary on Twitter

Not sure how to interpret a trial for a drug plus Remdesivir vs Remdesivir alone when you don't know if Remdesivir works. @NEJM today for this combo, which has already received FDA EUAhttps://t.co/tpmHPFPJX1 pic.twitter.com/Tmue99oJnV

— Eric Topol (@EricTopol) December 11, 2020